About Absorption
Absorption is a company based in Exton (United States) founded in 1996 was acquired by Pharmaron in November 2020. Absorption has completed 1 acquisition, including TGA Sciences. Absorption operates in a competitive market with competitors including Gubra, Tigermed, BioQual, Gentronix and Shanghai Semero Biotechnology, among others.
- Headquarter Exton, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Pharmaron
(Nov 09, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Absorption
Unlock access to complete
Funding Insights of Absorption
Detailed funding history for Absorption
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Absorption
Absorption has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Pharmaron.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug discovery and development services for small molecules are provided.
|
Locked | Locked | Locked |
Investor details for Absorption
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Absorption
Absorption has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include TGA Sciences.
Investment portfolio details for Absorption
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
CRO that specializes in the development and validation of immunoassay systems and preclinical studies
|
Locked | Locked | 1998 | Locked |
Complete acquisition details for Absorption
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Absorption
Detailed financials for Absorption
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Absorption Comparisons
Peer comparison for Absorption
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Absorption
Absorption operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gubra, Tigermed, BioQual, Gentronix and Shanghai Semero Biotechnology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Preclinical CRO services for NAFLD/NASH, diabetes, and obesity are provided.
|
|
| Locked | Locked | Locked |
Drug development and preclinical services are provided by Tigermed.
|
|
| Locked | Locked | Locked |
Contract research on infectious disease models is conducted.
|
|
| Locked | Locked | Locked |
In-vitro and in-vivo genetic toxicology screening services are provided.
|
|
| Locked | Locked | Locked |
Diversified preclinical services for brain-related disorders are provided.
|
|
| Locked | Locked | Locked |
Preclinical services in immunology, regeneration, neuroscience, and histology are provided.
|
Detailed competitors of Absorption
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Absorption
Complete news archive for Absorption
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Absorption
Absorption was founded in 1996.
Absorption is headquartered in Exton, United States. It is registered at Exton, Pennsylvania, United States.
Absorption Systems is a preclinical contract research organisation serving the pharmaceutical, biotechnology, and medical device industry. Their drug delivery and development services include physicochemical properties, protein and tissue binding, metabolism, permeability, in vitro dissolution absorption system, drug transporters and pharmacokinetics. Their preclinical medical device testing services include research protocols, model development, feasibility studies, safety and efficacy, physician training, cadaver studies, histopathological support and bioanalytical support. The company also specializes in preclinical ocular testing (in vitro and in vivo).
Absorption has made 1 acquisition, including TGA Sciences.
Absorption has 1 investor. Key investors include Pharmaron.